Search

for
Search:

Research

5 / 1000+ results

research Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus

52 citations , March 2007 in “Dermatologic Therapy”

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

research Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures

40 citations , October 2012 in “Journal of the American Academy of Dermatology”

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

research Clascoterone: First Approval

27 citations , October 2020 in “Drugs”

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

research Class III Peroxidases PRX01, PRX44, and PRX73 Control Root Hair Growth in Arabidopsis thaliana

19 citations , May 2022 in “International journal of molecular sciences”

PRX01, PRX44, and PRX73 are essential for root hair growth in Arabidopsis thaliana.

research Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation

16 citations , April 2024 in “Proceedings of the National Academy of Sciences”

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

View more "claws" in research →

Learn

1 / 801 results

learn Clascoterone

a novel topical treatment that inhibits DHT on androgen receptors

View more "claws" in learn →

Community Join

5 / 1000+ results

community Why are people so negative regarding Clascoterone (Breezula)?

in Treatment 18 upvotes 2 months ago

Clascoterone (Breezula) shows promising hair growth results, but skepticism remains due to past disappointments with new treatments. It may be a good alternative for those who can't tolerate finasteride or dutasteride, and can potentially be combined with them and minoxidil for better results.

community Clascoterone full results in July

in Research/Science 13 upvotes 2 months ago

Clascoterone's full trial results are expected by mid-July 2026, but skepticism exists about timely release. Clascoterone is available at 5% from some telehealth companies.

community Do you think clascoterone is overhyped

in Treatment 14 upvotes 3 months ago

Clascoterone is considered overhyped and not as effective as finasteride or dutasteride, but it may be useful as a supportive treatment in combination with other therapies. Users express skepticism about its effectiveness compared to clinical trials, with some suggesting it could be beneficial for those who cannot tolerate other treatments.

community Clascoterone is the way to go if you cannot use DHT blockers

in Chat 11 upvotes 3 months ago

Clascoterone is suggested as an alternative for those who experience side effects from finasteride and dutasteride. It is not widely available yet, but some users are obtaining it from compounding pharmacies or suppliers like Echemi.